T&R Biofab Past Earnings Performance
Past criteria checks 0/6
T&R Biofab's earnings have been declining at an average annual rate of -19.9%, while the Medical Equipment industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 14.1% per year.
Key information
-19.9%
Earnings growth rate
-7.4%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 14.1% |
| Return on equity | -62.6% |
| Net Margin | -291.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
Is T&R Biofab (KOSDAQ:246710) Using Debt Sensibly?
Feb 26
Do Insiders Own Lots Of Shares In T&R Biofab Co., Ltd. (KOSDAQ:246710)?
Mar 09Can You Imagine How T&R Biofab's (KOSDAQ:246710) Shareholders Feel About The 65% Share Price Increase?
Jan 12
Do Institutions Own T&R Biofab Co., Ltd. (KOSDAQ:246710) Shares?
Nov 18Revenue & Expenses Breakdown
How T&R Biofab makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 4,937 | -14,369 | 8,819 | 5,255 |
| 31 Mar 24 | 4,795 | -17,487 | 8,159 | 4,830 |
| 31 Dec 23 | 5,199 | -13,419 | 7,695 | 4,399 |
| 30 Sep 23 | 4,933 | -18,225 | 9,876 | 4,708 |
| 30 Jun 23 | 5,394 | -16,705 | 9,558 | 4,516 |
| 31 Mar 23 | 5,540 | -10,071 | 8,803 | 4,009 |
| 31 Dec 22 | 5,755 | -10,337 | 8,775 | 3,857 |
| 30 Sep 22 | 5,705 | -67,559 | 6,038 | 3,471 |
| 30 Jun 22 | 4,938 | -66,664 | 5,896 | 3,448 |
| 31 Mar 22 | 4,302 | -72,046 | 6,080 | 3,363 |
| 31 Dec 21 | 3,235 | -70,068 | 5,700 | 3,285 |
| 30 Sep 21 | 2,444 | -9,475 | 4,987 | 2,818 |
| 30 Jun 21 | 3,999 | -8,428 | 4,765 | 2,708 |
| 31 Mar 21 | 6,914 | -5,901 | 4,393 | 2,942 |
| 31 Dec 20 | 6,805 | -5,604 | 4,138 | 2,951 |
| 30 Sep 20 | 6,829 | -5,404 | 4,268 | 3,334 |
| 30 Jun 20 | 4,973 | -5,063 | 4,189 | 3,081 |
| 31 Mar 20 | 1,594 | -6,187 | 4,062 | 2,644 |
| 31 Dec 19 | 1,287 | -6,251 | 4,424 | 2,230 |
| 30 Sep 19 | 1,089 | -6,186 | 4,357 | 1,967 |
| 30 Jun 19 | 1,047 | -5,719 | 3,978 | 1,856 |
| 31 Mar 19 | 1,143 | -5,382 | 3,757 | 1,874 |
| 31 Dec 18 | 974 | -4,693 | 3,011 | 1,960 |
| 30 Sep 18 | 961 | -4,274 | 2,799 | 1,749 |
| 30 Jun 18 | 800 | -4,168 | 2,643 | 1,752 |
| 31 Mar 18 | 501 | -4,095 | 2,464 | 1,698 |
| 31 Dec 17 | 406 | -4,058 | 2,457 | 1,647 |
| 31 Dec 16 | 274 | -3,020 | 2,610 | 385 |
| 31 Dec 15 | 73 | -1,240 | 977 | 84 |
| 31 Dec 14 | 6 | -496 | 345 | 45 |
Quality Earnings: A246710 is currently unprofitable.
Growing Profit Margin: A246710 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A246710 is unprofitable, and losses have increased over the past 5 years at a rate of 19.9% per year.
Accelerating Growth: Unable to compare A246710's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A246710 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.7%).
Return on Equity
High ROE: A246710 has a negative Return on Equity (-62.64%), as it is currently unprofitable.